Aehr Test Systems, Inc. provides test solutions for testing, burn-in, and semiconductor devices at wafer level, singulated die, and package level in the United States, Asia, Europe, and the Middle East. The company offers FOX-XP and FOX-NP systems, which are full wafer contact and singulated die/module test and burn-in systems that test, burn-in, and stabilize a range of devices, including silicon carbide-based (SIC) and gallium nitride (GAN) power semiconductors; 2D and 3D sensors used in mobile phones, tablets, and other computing devices; memory semiconductors; processors; microcontrollers; systems-on-a-chip; and photonics and integrated optical devices used in AI. It also provides the FOX-CP system, a single-wafer compact test solution for logic, memory, and photonic devices; and the FOX WaferPak Contactor, a full wafer contactor capable of testing wafers up to 300mm that enables integrated circuit manufacturers to perform test, burn-in, and stabilization of full wafers on the FOX-P systems. In addition, the company offers the FOX DiePak Carrier, which allows testing, burn-in, and stabilization of singulated bare die and modules; FOX WaferPak Aligner; and FOX DiePak Loader. Further, it provides system installation and repair, applications engineering support, spare parts inventories, customer training, and documentation services. The company sells its products in the United States, Germany, Japan, the Philippines, and Taiwan through distributors and sales representatives. It serves semiconductor manufacturers, semiconductor contract assemblies, electronics manufacturers, and burn-in and test service companies. Aehr Test Systems, Inc. was incorporated in 1977 and is headquartered in Fremont, California.
Country
Sector
Themes
Also in
Price· split & dividend adjusted
No price history for this asset yet.
News & notes movingAEHR
AEHR▼
Aehr Test Systems CEO Sells $5.2 Million in Shares
Aehr Test Systems President and CEO Gayn Erickson sold 40,000 shares of common stock on August 12, 2026, in a transaction valued at $5.2 million. The sale was executed entirely through indirect holdings held by a trust, reducing that specific interest by 20%, while Erickson maintained direct ownership of 197,521 shares. The shares were sold at a weighted average price of $130.84, slightly above the $129.23 market close on the transaction date. Following the transaction, Erickson retains a total beneficial interest of approximately 355,000 shares, including unvested restricted stock units and unvested restricted shares. The sale occurred while the company reported trailing twelve-month revenue of $50.9 million and a net loss of $7.1 million.
Aehr Test Systems shares have surged 72.2% over the past month, far outpacing the broader industry's 7.4% gain and the S&P 500's 2.9% rise. The rally follows record fourth-quarter fiscal 2026 bookings of $60.7 million and an effective backlog of about $100.6 million, which boosted confidence in demand for its semiconductor test and burn-in systems used in AI processors, silicon photonics, and power devices. For fiscal 2027, the Zacks Consensus Estimate projects EPS of 70 cents, up sharply from 3 cents a year ago, with revenues expected to reach $140.20 million, a 180.4% increase. The company also received a follow-on production order from its lead silicon photonics customer for a fully automated FOX-XP multi-wafer burn-in system, scheduled to ship in the first half of 2027. Despite the strong growth outlook, the stock trades at 24.62 times forward sales, well above the industry average of 6.32 times, leaving little room for execution missteps.
Applied Digital, Celestica, and OPKO Health surge on strong earnings and raised outlooks
Applied Digital, Celestica, and OPKO Health were among Tuesday's biggest stock gainers after each reported quarterly results that beat expectations and raised their forward guidance. Applied Digital shares rose 4% as the AI infrastructure company posted a 407% year-over-year revenue surge to $258.7 million and adjusted earnings of $0.04 per share, driven by the on-time deployment of 175 megawatts of AI capacity at its Polaris Forge campus. Celestica gained 4% after revenue jumped 62% to $4.7 billion and adjusted EPS of $2.54 topped estimates, prompting the electronics manufacturer to lift its full-year 2026 revenue forecast to $20.5 billion and adjusted EPS outlook to $11.30, with management citing strong AI infrastructure demand and expecting 2027 revenue growth to accelerate further. OPKO Health climbed 9% as the company beat second-quarter revenue and earnings estimates, raised its full-year 2026 revenue guidance to a range of $560 million to $585 million, and narrowed its net loss to $0.01 per share, supported by a roughly 60% increase in pharmaceutical revenue that included $33.6 million in royalties and milestone payments. On the losing side, Aehr Test Systems fell 5% after filing a mixed shelf registration that investors viewed as a potential source of future dilution, while Universal Health Services slipped 4% after cutting its full-year 2026 non-GAAP EPS guidance to a range of $22.28 to $23.65 and reporting second-quarter earnings below expectations amid a 9% rise in operating expenses to $4.1 billion.
Wall Street ends lower as chip selloff and earnings dominate the week
Wall Street's major averages ended the week lower as a prolonged sell-off in semiconductor stocks weighed on sentiment and investors digested the start of second-quarter earnings season. The S&P 500 lost 1.6%, the Nasdaq Composite dropped 2.9%, and the Dow declined 0.9%. IBM shares plunged about 27% after the company released disappointing preliminary second-quarter results, with CEO Arvind Krishna citing missed large deals and a faster-than-expected shift in customer spending toward AI infrastructure. Taiwan Semiconductor Manufacturing reported better-than-expected second-quarter results and raised its 2026 revenue growth outlook for the second time this year, with net revenue growing 33.7% year-over-year to $40.20 billion and EPS per ADR surging about 74% to $4.31. PayPal shares advanced over 20% after reports that Stripe and Advent International jointly offered to acquire the company for $60.50 per share, valuing it at more than $53 billion. Among other notable movers, Aehr Test Systems jumped about 22% on stronger-than-expected quarterly results and record bookings, while Yum! Brands fell nearly 10% amid a U.S. health investigation into a cyclosporiasis outbreak potentially linked to Taco Bell lettuce. The semiconductor sell-off continued with SanDisk down 24.6%, Marvell Technology down 17.4%, and Western Digital down 13.6%.
Aehr Test Systems Shares Surge 20.9% After Record Bookings Confirm AI Pivot
Aehr Test Systems shares jumped 20.9% this week after the company reported record bookings and confirmed a successful shift from electric vehicle silicon carbide chips to AI processors. Bookings reached $60.7 million in the fiscal fourth quarter, bringing second-half bookings to $97.9 million, well above the high end of the $60 million to $80 million guidance range. CEO Gayn Erickson said AI accelerators, CPUs, and network processors accounted for approximately 71% of total annual revenue, compared with over 95% of business tied to EV silicon carbide chips two years ago. Based on orders and a $100 million backlog, management expects fiscal 2027 revenue of $130 million to $150 million, up from $50 million in fiscal 2026, and a return to profitability.
Aehr Test Systems shares jump 30% on earnings beat and strong fiscal 2027 guidance
Aehr Test Systems shares surged 30% after the semiconductor test and burn-in equipment provider reported fiscal fourth-quarter results that exceeded Wall Street expectations and issued a fiscal 2027 revenue forecast well above analyst estimates. The company posted adjusted earnings of $0.11 per diluted share for the quarter ended May 29, 2026, compared with expectations for a loss of $0.01 per share, while revenue came in at $18.8 million, ahead of the $17.9 million consensus. Aehr also reported record quarterly bookings of $60.7 million, contributing to a backlog of $80.6 million as of May 29, with an effective backlog of approximately $100.6 million including post-quarter bookings. For fiscal 2027, management forecast revenue of between $130 million and $150 million, significantly above analyst expectations of roughly $85 million. The company ended the fiscal year with $116.5 million in cash, cash equivalents and restricted cash, up from $37.1 million at the end of the prior quarter.
PayPal surges on reported $53 billion takeover bid from Stripe and Advent
PayPal Holdings surged more than 20% in premarket trading after Reuters reported that payments giant Stripe and private equity firm Advent International submitted a joint takeover offer valuing the company at more than $53 billion. The consortium offered $60.50 per share, a roughly 28% premium to PayPal's previous close. The proposed acquisition would be one of the largest fintech deals in years. Separately, Aehr Test Systems rallied 29% after fiscal fourth-quarter adjusted earnings of $0.11 per share beat expectations for a $0.01 loss, with revenue up 33% year-on-year to $18.8 million. Ernexa Therapeutics soared 30% on preclinical data for its ovarian cancer therapy candidate, Redwire Corp. rose 4.6% on $21.5 million in follow-on orders for Stalker unmanned aerial systems, and XPeng gained 4% after the Wall Street Journal reported plans to launch a humanoid robot globally in 2027 with monthly production capacity exceeding 1,000 units by year-end. On the downside, Pentair tumbled nearly 20% after cutting its full-year outlook, announcing the CFO's departure, and disclosing preliminary second-quarter sales well below guidance due to inventory destocking in its pool products business.
Alphabet signs deal for its largest US solar project, Aehr Test Systems surges on earnings beat
Alphabet has signed an agreement with Cypress Creek Energy to develop the Steel River Energy Center, its largest solar project in the United States, located in Mississippi County, Arkansas. Aehr Test Systems surged over 25% in after-hours trading after reporting Non-GAAP EPS of $0.11, beating estimates by $0.12, and revenue of $18.8 million, up 33.4% year-over-year. Phoenix Education Partners shares dropped 11% despite posting Non-GAAP EPS of $1.43, topping estimates by $0.11, and revenue of $271.8 million, flat year-over-year but ahead of expectations by $0.55 million.
Small-Cap ETF Could Be the Best Investment of 2026 as Russell 2000 Surges 20%
Small-cap stocks were the best-performing asset class in the first half of 2026, with the Russell 2000 index up 20% year to date, outperforming the S&P 500, Nasdaq, S&P 400 mid-cap index, and Russell 1000. Over the past 12 months, the Russell 2000 has returned 35%, compared to 27% for the Nasdaq and 20% for the S&P 500. The surge is driven by a rotation out of overvalued large-caps, an expanding AI supply chain benefiting small-cap semiconductor stocks like Aehr Test Systems, MaxLinear, Navitas, and Wolfspeed, a robust mergers and acquisitions market, and small-cap earnings expected to grow 38% to 48% in 2026, roughly double the S&P 500's rate. While declining rates have helped, potential Federal Reserve rate hikes and inherent volatility pose risks, making a small-cap ETF a prudent choice. An actively managed option like the Fidelity Enhanced Small-Cap Core ETF, up 26% year to date, offers diversified exposure.
Leverage Shares by Themes Launches 2X Long Aehr Test Systems ETF
Leverage Shares by Themes launched a new 2X single-stock leveraged ETF tied to Aehr Test Systems, trading on Cboe under ticker AEHG starting June 26, 2026. The fund targets 200% daily exposure to Aehr Test Systems (NASDAQ: AEHR) and carries a 0.99% expense ratio. Paul Marino, Chief Revenue Officer of Themes ETFs, said the product offers active traders amplified exposure to a company positioned in AI infrastructure, electric vehicles, and advanced computing.
Prosper Stars & Stripes Covered Its Short Position in Aehr Test Systems
Prosper Stars & Stripes, a long/short equity fund, covered its short position in Aehr Test Systems during the first quarter of 2026. The fund cited Aehr as the largest detractor in its short book for the quarter, noting that the company's wafer-level test and burn-in equipment remains a niche solution with limited adoption. Aehr's revenue fell 11% year-over-year to approximately $59 million in fiscal 2025, and consensus estimates point to a further 17% decline to roughly $50 million in fiscal 2026. The fund highlighted significant customer concentration, with ON Semiconductor accounting for about 80% of revenue, and a narrow use case focused on silicon carbide devices for electric vehicles. Despite management's emphasis on growth opportunities in AI and silicon photonics, Prosper Stars & Stripes concluded that Aehr's business reality is weaker than its high multiples imply, but covered the position in adherence to its risk management discipline.
Aehr Test Systems Stock Spikes on New Production Order
Aehr Test Systems shares experienced a sharp upward move following the announcement of a new production order, reflecting growing confidence in the company's positioning within the semiconductor test equipment market. The order arrives amid unprecedented demand driven by artificial intelligence infrastructure buildout and the reshoring of chip manufacturing to the United States, with hyperscale technology companies projected to spend about $755 billion on AI-related capital expenditures in 2026. Aehr's order likely reflects expanding need for wafer-level burn-in and test solutions as chipmakers ramp production of silicon carbide, gallium nitride, and other advanced semiconductor materials. The new order extends backlog visibility, supports stronger utilization of manufacturing capacity, and reinforces expectations for revenue and margin expansion. Despite the positive commercial validation, Wall Street sees AEHR shares as overvalued, with a consensus rating of Moderate Buy and a mean price target of nearly $64 signaling potential downside of more than 40% from current levels.
Aehr Test Systems stock jumps on repeat order for wafer burn-in systems
Aehr Test Systems shares surged as much as 17.8% in early trading Wednesday after the company announced a repeat order for its automated wafer burn-in systems from a leading maker of networking products and fiber-optic transceivers for data centers. The order is for a fully loaded FOX-XP system capable of testing up to nine silicon wafers at a time, with delivery expected within six months. While the dollar amount was not disclosed, the order is part of a larger relationship that includes at least one earlier system shipment and a forecast for additional systems this calendar year. This marks at least the sixth full-system order since mid-February, each representing multi-million dollar revenue boosts for a company that recorded just $45 million in total sales last year. The stock has soared 937% over the past 52 weeks and trades at 81 times trailing sales.
UniQure surges 67.5% premarket on FDA support for Huntington's gene therapy
UniQure shares surged 67.5% in premarket trading after the gene therapy developer said the U.S. Food and Drug Administration agreed that three-year data from its Phase I/II study of AMT-130 could serve as the primary basis for a Biologics License Application seeking accelerated approval for Huntington's disease. Aehr Test Systems jumped 11% after announcing a follow-on production order for a fully automated FOX-XP wafer-level burn-in system from a major silicon photonics customer, with delivery expected within six months. Genco Shipping & Trading rose 8% after Diana Shipping increased its acquisition proposal to $27.34 per share in cash and stock, representing a substantial premium. Snap shares remained under pressure following a 9.6% drop in the previous session after unveiling its standalone augmented reality glasses, with investors skeptical about the commercial prospects. Leidos Holdings slipped 1.3% after BofA Securities downgraded the defense contractor to Neutral from Buy and cut its price target to $125 from $200.